YDES
YD Bio Ltd.

164
Loading...
Loading...
News
all
press releases
News Placeholder
YD Bio Stock Fuels Retail-Trader Excitement After Nasdaq Listing Through Breeze SPAC Deal
YD Bio trades under YDES following the Breeze merger, with a pipeline that spans cancer detection and eye disease therapies.
Stocktwits·9d ago

Latest YDES News

View

Advertisement. Remove ads.

Advertisement. Remove ads.